LATEST ALERTS
It could have been so much worse: 2020 was CBD’s year in the waiting-room
1st January 2021 - News analysis |
For many 2020 will always carry an asterisk. The CBD industry was – overall – more fortunate than many other sectors
EU regulation
A world of change – but don’t expect 2021 to deliver very much new regulation
31st December 2020 - News analysis |
Multiple jurisdictions are planning significant legislation on both CBD and hemp-related matters, but it seems regulation in 2021 could be defined as much by what doesn’t happen as by the progress made
The long wait goes on for a successful European novel food application
28th December 2020 - News analysis |
Officials from the European Commission (EC) met with CBD-Intel to discuss the status of novel food applications in light of the ruling in the Kanavape case
Brexit: more clarity for international trade, but change ahead for vapes?
24th December 2020 - News analysis |
While a post-Brexit regulatory review in the UK is likely to focus much more on nicotine vaping than on CBD, equally there are likely to be knock-on effects for providers of CBD products – whether or not intended
Regulatory report: the implications of the Kanavape case on CBD in the EU
14th December 2020 - Regulatory reports |
The implications of the Kanavape ruling could be far-reaching. This report examines the decision by the Court of Justice of the European Union (CJEU) and some of its likely consequences
Kanavape ruling could kick-start French CBD industry – but not everyone’s happy
3rd December 2020 - News analysis |
The decision by the Court of Justice of the European Union (CJEU) in the Kanavape cape that CBD cannot be treated as a narcotic has been welcomed in France – though not by the official regulatory bodies
Switzerland opens a door by allowing non-EU catalogue varietals to be grown
24th November 2020 - News analysis |
Starting next year, Switzerland will allow the commercial growing of all hemp varieties with a THC content below 1% – even those that are not in the European Union catalogue
EU court rules at last in Kanavape case: CBD cannot be deemed a narcotic
19th November 2020 - News analysis |
CBD must not be regarded a narcotic drug, even under UN Convention definitions, whether or not it is extracted from hemp flowers, the Court of Justice of the European Union (CJEU) has ruled
Little fear of a glut in the UK market if EU decides to classify CBD as a narcotic
3rd November 2020 - News analysis |
Companies do not feel much risk of a glut of CBD-containing food, drink and dietary supplement products or cannabinoid ingredients coming into the UK market if the EU classifies CBD as a narcotic
No plans to ease restrictions on flowers, says UK Home Office
29th October 2020 - News analysis |
The UK Home Office has stated it has no plans to ease restrictions on using flowers for extraction before the EU exit transition period ends on 1st January 2021
EU ‘tax’ on plastic packaging waste could mean another tangle of red tape
20th October 2020 - News analysis |
EU member states will have to decide how to implement a planned European levy on non-recycled plastic packaging waste – to fund it from national budgets or make industry pay for the waste it produces
German city’s ban on foods containing natural CBD extracts faces legal test
7th October 2020 - News analysis |
A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International
Opposing politicians attack European Commission view on ‘narcotic’ CBD
15th September 2020 - News analysis |
MEPs with very different political outlooks have attacked the European Commission’s initial opinion that CBD could be classed under United Nations conventions as a narcotic
CBD food products to remain illegal for three years
1st September 2020 - Press releases , Resources |
FOR IMMEDIATE RELEASE CBD food products to remain illegal for three years New report from CBD-Intel explores issues surrounding CBD as a novel food Don’t expect to see legal CBD food and drink products before 2023 at the very earliest, a new report from CBD-Intel warns. The use of CBD as a food ingredient has been on hold since European » Continue Reading.
Worse delays feared for European CBD novel food authorisations
27th August 2020 - News analysis |
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
German firm waits to hear whether new CBD oil will be deemed ‘novel food’
24th August 2020 - News analysis |
A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements
Regulatory report: EU narcotics law leaves question mark over future of CBD
3rd August 2020 - Regulatory reports |
Confusion over whether CBD should be considered a narcotic drug has developed into a major question mark over the substance’s future in Europe
Think tank urges Poland’s government to raise THC limit for hemp growers
16th July 2020 - News analysis |
An influential Polish think tank has released a report calling for a relaxation of Poland’s cannabis regulations
EIHA launches novel food application consortium project
26th June 2020 - News analysis |
A new consortium project from the EIHA will put four separate novel food applications in to European and UK authorities after performing the necessary toxicological and safety studies
EC takes time out on novel food to decide if CBD is legally a narcotic
24th June 2020 - News analysis |
Progress on novel food authorisations for non-synthetic cannabinoids will be paused until European regulators decide whether extracts from hemp flowers constitute a drug under narcotics laws, CBD-Intel has learned
French flavour house Robertet teams up to tackle European CBD market
17th June 2020 - News analysis |
Major French flavours and fragrance manufacturer Robertet is making its first foray into European cultivation and processing of hemp oil extracts in a joint venture with Swiss CBD and hemp producer Alponics
Regulatory report: GMP requirements for cosmetics
11th May 2020 - Regulatory reports |
This short regulatory report provides an overview of the current GMP regulations for cosmetics being place on the market in the EU
Regulatory report: the path to the market for CBD foods under Article 4
13th February 2020 - Regulatory reports |
The aim of this report is to bring some clarity to the process of placing a food product on the EU market, looking at the options of Article 4 and Article 10
Small packet label exemptions: a guide to European CLP regulation, part 3
22nd November 2019 - Regulatory reports |
CBD-Intel examines possible exemptions for some small packages in EU regulations concerning classification, labelling and packaging (CLP)
Toxicity and notifications: a guide to European CLP regulations, part 2
24th September 2019 - Regulatory reports |
This report continues to look at the European Union’s CLP regulations and covers hazardous chemicals and obligations to notify, the part played by Poison Centres and the need for UFIs
Toxicity and notifications: a guide to European CLP regulations, part 1
24th September 2019 - Regulatory reports |
The EU’s Classification, Labelling and Packaging (CLP) Regulations classify all chemical substances and mixtures according to their toxicity levels. Part 1 of our report looks in detail at this legislation
CBD-based epilepsy drug Epidyolex gets the green light from Europe
23rd September 2019 - News analysis |
Epidyolex, the CBD-based medicine used to treat rare forms of epilepsy, has been approved by the European Medicines Agency (EMA)
CBD in e-liquids: a guide for the EU
20th September 2019 - Regulatory reports |
CBD for vaping is not as cut-and-dried as you might hope, despite vaping products having a clear regulatory regime in Europe. CBD-Intel looks at the different rules for CBD and vaping across the EU.
European Commission differentiates CBD as cosmetic ingredient
10th April 2019 - News analysis |
CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity
EU agriculture committee approves proposal to raise THC limit to 0.3%
3rd April 2019 - News analysis |
The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC
A guide to EU novel food rules for cannabinoid-containing edibles
26th March 2019 - Regulatory reports |
Under current EU rules, cannabinoid-containing hemp extracts could require pre-market authorisation as they are now considered to be novel foods. CBD-Intel explains how the rules work
EU states could deem CBD, other cannabinoids illegal in cosmetics
21st February 2019 - Regulatory reports |
According to EU authorities, CBD and other cannabis extracts could be deemed illegal as an ingredient in cosmetics. However, individual member states have not made the same interpretation of the rules
Europe votes for medical cannabis – in theory and on certain conditions
14th February 2019 - News analysis |
The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process
Radical change in EU guidance on cannabinoids as novel food
22nd January 2019 - News analysis |
No food item should contain any cannabinoid, including CBD, in the EU without prior novel food ingredient authorisation following a change by European authorities – though this is open to interpretation
Are CBD edibles ‘novel food’? The EU debates this vital question
7th January 2019 - Regulatory reports |
The CBD industry is currently navigating a complex and changing regulatory landscape across the European Union. CBD-Intel brings some light to the obscure area of novel food regulation – and asks the vital questions
